129 related articles for article (PubMed ID: 14985333)
1. Modulation of beta-catenin phosphorylation/degradation by cyclin-dependent kinase 2.
Park CS; Kim SI; Lee MS; Youn CY; Kim DJ; Jho EH; Song WK
J Biol Chem; 2004 May; 279(19):19592-9. PubMed ID: 14985333
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase 2 regulates the interaction of Axin with beta-catenin.
Kim SI; Park CS; Lee MS; Kwon MS; Jho EH; Song WK
Biochem Biophys Res Commun; 2004 Apr; 317(2):478-83. PubMed ID: 15063782
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
4. beta-catenin is a target for the ubiquitin-proteasome pathway.
Aberle H; Bauer A; Stappert J; Kispert A; Kemler R
EMBO J; 1997 Jul; 16(13):3797-804. PubMed ID: 9233789
[TBL] [Abstract][Full Text] [Related]
5. Cdk2-dependent Inhibition of p21 stability via a C-terminal cyclin-binding motif.
Zhu H; Nie L; Maki CG
J Biol Chem; 2005 Aug; 280(32):29282-8. PubMed ID: 15964852
[TBL] [Abstract][Full Text] [Related]
6. Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway.
Yun J; Chae HD; Choi TS; Kim EH; Bang YJ; Chung J; Choi KS; Mantovani R; Shin DY
J Biol Chem; 2003 Sep; 278(38):36966-72. PubMed ID: 12857729
[TBL] [Abstract][Full Text] [Related]
7. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
[TBL] [Abstract][Full Text] [Related]
9. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
Albanese C; Wu K; D'Amico M; Jarrett C; Joyce D; Hughes J; Hulit J; Sakamaki T; Fu M; Ben-Ze'ev A; Bromberg JF; Lamberti C; Verma U; Gaynor RB; Byers SW; Pestell RG
Mol Biol Cell; 2003 Feb; 14(2):585-99. PubMed ID: 12589056
[TBL] [Abstract][Full Text] [Related]
10. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
11. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
Christian SL; Sims PV; Gold MR
J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
[TBL] [Abstract][Full Text] [Related]
12. Substitution of a glycogen synthase kinase-3beta phosphorylation site in presenilin 1 separates presenilin function from beta-catenin signaling.
Kirschenbaum F; Hsu SC; Cordell B; McCarthy JV
J Biol Chem; 2001 Mar; 276(10):7366-75. PubMed ID: 11104755
[TBL] [Abstract][Full Text] [Related]
13. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
[TBL] [Abstract][Full Text] [Related]
14. Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve beta-catenin and cyclin D1 down-regulation.
Li H; Liu L; David ML; Whitehead CM; Chen M; Fetter JR; Sperl GJ; Pamukcu R; Thompson WJ
Biochem Pharmacol; 2002 Nov; 64(9):1325-36. PubMed ID: 12392815
[TBL] [Abstract][Full Text] [Related]
15. Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells.
Tintignac LA; Leibovitch MP; Kitzmann M; Fernandez A; Ducommun B; Meijer L; Leibovitch SA
Exp Cell Res; 2000 Aug; 259(1):300-7. PubMed ID: 10942602
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta induced G(1) cell cycle arrest requires the activity of the proteasome pathway. Transforming growth factor.
Zhang F; Mönkkönen M; Roth S; Laiho M
Exp Cell Res; 2002 Dec; 281(2):190-6. PubMed ID: 12460649
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.
Easwaran V; Song V; Polakis P; Byers S
J Biol Chem; 1999 Jun; 274(23):16641-5. PubMed ID: 10347231
[TBL] [Abstract][Full Text] [Related]
18. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.
Clurman BE; Sheaff RJ; Thress K; Groudine M; Roberts JM
Genes Dev; 1996 Aug; 10(16):1979-90. PubMed ID: 8769642
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2.
Lents NH; Keenan SM; Bellone C; Baldassare JJ
J Biol Chem; 2002 Dec; 277(49):47469-75. PubMed ID: 12359725
[TBL] [Abstract][Full Text] [Related]
20. Proteasome-mediated destruction of the cyclin a/cyclin-dependent kinase 2 complex suppresses tumor cell growth in vitro and in vivo.
Chen W; Lee J; Cho SY; Fine HA
Cancer Res; 2004 Jun; 64(11):3949-57. PubMed ID: 15173007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
